Thomas Jozefiak Email

Co-Founder, Chief Scientific Officer . Glyscend

Current Roles

Employees:
18
Revenue:
$2.8M
About
Founded in 2014, Glyscend is dedicated to the development of a truly revolutionary approach to treating type 2 diabetes. The company began with the insight that bariatric surgery can lead to the immediate remission of the disease, and has since been engaged in the development of a non-invasive approach which will act on the same mechanism as surgery but fit within the current care pathway.
Glyscend Address
1812 Ashland Avenue
Baltimore, MD
United States
Glyscend Email

Past Companies

Glyscend IncorporatedCo-Founder, Chief Scientific Officer
GlycologixScientific Founder & Advisor
Jozefiak Biomaterials ConsultingPrincipal

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.